1. Home
  2. QDEL vs EVO Comparison

QDEL vs EVO Comparison

Compare QDEL & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuidelOrtho Corporation

QDEL

QuidelOrtho Corporation

HOLD

Current Price

$12.25

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.13

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QDEL
EVO
Founded
1979
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
934.1M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
QDEL
EVO
Price
$12.25
$3.13
Analyst Decision
Hold
Strong Buy
Analyst Count
4
1
Target Price
$28.25
$7.00
AVG Volume (30 Days)
2.6M
95.5K
Earning Date
05-05-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
45.35
N/A
EPS
N/A
N/A
Revenue
$2,730,200,000.00
N/A
Revenue This Year
$3.51
$1.37
Revenue Next Year
$3.86
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.86
$2.31
52 Week High
$37.24
$4.80

Technical Indicators

Market Signals
Indicator
QDEL
EVO
Relative Strength Index (RSI) 40.56 56.90
Support Level $10.86 $2.87
Resistance Level $17.78 $3.78
Average True Range (ATR) 0.98 0.11
MACD 0.17 -0.00
Stochastic Oscillator 21.15 45.10

Price Performance

Historical Comparison
QDEL
EVO

About QDEL QuidelOrtho Corporation

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: